Promoter holding
64.27%
MC
Midas Care Pharmaceuticals Pvt Ltd - Due diligence report
A 360° intelligence report on Midascare: trust score, financial health, credit view, compliance, directors, growth and distress signals - ge…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Midascare — 360° Intelligence Report
Generated from MCA filings & public records78/100
Trust Score
Low Risk
Midascare is assessed as Low Risk with a Trust Score of 78/100. Midascare is an active private limited indian non-government company incorporated in 1986, operating in the FMCG sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and moderate financial risk profile.
Report generated on 17 Jul 2026 from the latest processed filings. Midas Care Pharmaceuticals Pvt Ltd snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
78/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
66/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
70/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 55/100 Moderate
- Liabilities ≈ 38% EBITDA - stretched.
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 1 open (15.00 cr) · 10 satisfied (138.39 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Hdfc Bank Limited | 4 | 48.0 cr |
| Icici Bank Limited | 1 | 48.0 cr |
| Deutsche Bank Ag | 1 | 48.0 cr |
| Bank Of Baroda | 3 | 48.0 cr |
| The Saraswat Co Op Bank Of Ltd | 1 | 48.0 cr |
| Bank Of Broda | 1 | 48.0 cr |
Compliance Score: 66/100 Moderate
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2024).
- Litigation present in 2 court forum(s).
- Delayed payments to MSME suppliers disclosed (35 disclosure(s)).
- 7 active GST registration(s).
Legal cases on record (2)
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| NANDAN BRIJBANDHU GUPTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SHIVANGI GUPTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SANGITHAA GUPTA BRIJBANDHU | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 3 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2024 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Midas Care Holdings Pvt Ltd
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 1 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Midas Care Holdings Pvt Ltd | Holding Company | 74.00% |
Key managerial personnel: SANGITHAA GUPTA BRIJBANDHU (Managing Director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 40 · Distress 75
Growth signals & trust indicators
Operating for 40+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
1 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 50.53 Lakh.
2 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence72/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment62/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 1 open charge(s) of 15.00 cr already registered.
- Compliance gaps should be priced into terms.
Investor view60/100
Mixed indicators
Growth quality and scalability through an investor lens.
- No clear growth signals in the filed years.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events16 Aug 2025
Charge created
Hdfc Bank Limited - 15.00 cr
30 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
24 Dec 2020
Charge satisfied
Icici Bank Limited
07 Aug 2020
Charge satisfied
Hdfc Bank Limited
31 Mar 2020
Share transfer (FY 2020)
6401.00000000 shares to SHIVANGI GUPTA
03 Mar 2020
Charge satisfied
Deutsche Bank Ag
30 May 2018
Securities allotted
60000 Equity Shares - 6.00 Lakh raised
29 Sep 2017
Charge created
Hdfc Bank Limited - 7.30 cr
20 Jun 2014
Charge satisfied
Bank Of Baroda
17 Jun 2014
Charge satisfied
The Saraswat Co Op Bank Of Ltd
18 Sep 2013
Charge created
Icici Bank Limited - 14.50 cr
28 Nov 2011
Charge created
Deutsche Bank Ag - 2.50 cr
01 Mar 2011
Director appointed
NANDAN BRIJBANDHU GUPTA (Director)
16 Oct 2008
Charge created
Hdfc Bank Limited - 50.25 cr
10
Key Observations
Auto-generated from the data aboveRevenue declined 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Net worth is positive.
3 active director(s) / partner(s); board looks stable and experienced.
7 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Ingene Organics Private Limited | U51909MH2003PTC143444 | Mumbai, Maharashtra, India |
| Aveo Pharmaceutical | U74120MH2015PLC261024 | Palghar, Maharashtra, India |
| Neelgiri Chemicals Private Limited | U46691DL2023PTC414833 | Delhi, Delhi, India |
| Alkaloids Pvt Ltd. | U24114TS1992PTC206238 | Shaikpet, Telangana, India |
| Avalanche Impex Private Limited | U51909MH2016PTC286731 | Mumbai, Maharashtra, India |
| Maxim Pharmaceuticals Private Limited | U24239PN1998PTC013106 | Pune, Maharashtra, India |
| Cotec Healthcare | U24232UT1998PLC016093 | Roorkee, Uttarakhand, India |
| Wings Pharma | U74899DL1987PTC027499 | New Delhi, Delhi, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Midascare before audits and certifications: compliance score 66/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Midascare: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 40/100, margin trends, ownership structure and peer set for Midascare - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 78/100, distress signals and MSME payment-delay disclosures - know whether Midascare pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Midascare - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Midascare an active company?
Midascare has MCA status “Active” with a compliance score of 66/100 (Moderate).
Is Midascare financially healthy?
Midascare has a Financial Health Score of 70/100 (Moderate) based on its filed financial statements.
Should I do business with Midascare?
Its overall Trust Score is 78/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Midascare?
The ultimate holding entity is Midas Care Holdings Pvt Ltd. 3 active director(s) are on record.
Does Midascare have loans or charges against its assets?
1 open charge(s) are registered against its assets, and 10 earlier charge(s) stand satisfied.
Is Midascare up to date with its ROC filings?
Balance sheet slightly behind (Mar 2024). Overall compliance score: 66/100 (Moderate).
Is it risky to lend to Midascare?
Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
